European Pharmacopoeia adopts new standards to promote the development of mRNA vaccines
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Coronavirus/COVID-19EuropeEuropean CommissionPharmaceuticalsProduct developmentProduct LifecycleQuality Assurance and Control